Your trusted partner in China life scienceTM
Since our founding in January, 2007, ChinaBio® Group has created a broad platform of capabilities to help western life science and healthcare companies achieve success in China. Our consulting and advisory group has helped over 100 multinational companies and many SMEs find partnerships, acquisitions, novel technologies and funding in China. We have helped identify over 1,000 in-/out-licensing and M&A opportunities, and raise over $500M USD in funding in China. We have also organized more than 30 conferences in China including the highly regarded ChinaBio® Partnering Forum. which attracted over 850 attendees in 2015. ChinaBio® also maintains a robust set of proprietary databases and publishes the most widely read newsletter on the China life science industry, ChinaBio® Today.
ChinaBio® Group is headquartered in Zhangjiang Hi-Tech Park in Shanghai with offices in San Diego, Silicon Valley and Basel, Switzerland.
Shanghai's Dramatic and Ever-changing Skyline (Photo:Philipp Dormeier, EBD Group)
Our team of industry consultants, analysts and advisors based in Shanghai, the U.S. and Europe make ChinaBio
Your trusted partner in China life science™.
If you are a U.S. or European life science company looking to establish relationships or operations in China, or a China company seeking technology, partners or investors in the West, ChinaBio® has the talent and expertise to help.
- China strategy development
- Market / competitive analysis
- Technology and partner searches
- Opportunity Assessments
ChinaBio® organizes the premier life science investment and partnering conferences in China. Our premier event, ChinaBio® Partnering Forum, now in its 6th year, attracts over 850 industry executives from around the world.
BioPacific Investors was launched in 2013 to bring western life science and healthcare products and technology into China. BioPacific Investors focuses on commercial and near-commerical opportunities in the following areas:
- Medical devices
- Healthcare services
ChinaBio® maintains the most comprehensive and up-to-date proprietary databases on China's life science industry. We also regularly publish white papers and provide commissioned reports and research data to many of the industry's leaders.
- White papers
- Commissioned reports
- Custom research/surveys
- Proprietary databases
The most widely read newsletter on China's life science industry.
For more information about any of our services, please contact us.
Palo Alto, USA
October 1, 2015